Antiretroviral Therapy Cohort Collaboration
Studies
0
Estimate prognosis of HIV-1 positive, treatment naïve patients initiating highly active antiretroviral therapy (ART)
Visit ART-CC
Members
| Investigators | Contacts |
|---|---|
|
|
General Information
- Year created
- 2000
- Types of cohorts
-
- Patient/disease cohort
- Countries
-
- Austria
- Canada
- Greece
- France
- Netherlands
- Germany
- Spain
- Denmark
- Italy
- Switzerland
- United States of America
- Region
- Western Europe and North America
- Setting
- International
- Funding
- Currently supported by the US National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Criteria of cohort's to be included
- Prospective cohort studies are eligible to participate if they have enrolled at least 100 HIV-1–positive patients aged 16 years or older who have not previously received antiretroviral treatment, who began ART with a combination of at least three antiretroviral drugs after 1996, and who have been followed for a median of at least 1 year after the initiation of ART.
- Health topic
-
- Ageing
- Cancer
- Respiratory diseases
- Communicable diseases
- Biomedicine
- Other : HIV and Addictive behaviours
Participants
Number of participants
- Total
- 200,000
Age range of the samples
- Minimum age
- 16
- Maximum age
- 91
Methodology for harmonization and integration
- Strategy of harmonization
- Ex-post
- Data processing methods
-
- NA
- Type of infrastructure
- Data are centrally located
- Integrative data analysis
-
- Pooled analyses
- Software
-
- Stata
- SAS
- NA
- Supplementary information
- https://academic.oup.com/ije/article/43/3/691/757695 May, Margaret T., et al. "Cohort profile: antiretroviral therapy cohort collaboration (ART-CC)." International journal of epidemiology 43.3 (2014): 691-702.
Number of cohorts
- Total
- 20
- With harmonized data
- 20
- Will more cohorts be harmonized?
- Number of harmonized variables (max.)
- 20
Access
- Availability of metadata
- Under request
- Availability of individual data